S-Methyl-L-cysteine

S-Methyl-L-cysteine
Product Name S-Methyl-L-cysteine
CAS No.: 1187-84-4
Catalog No.: CFN70035
Molecular Formula: C4H9NO2S
Molecular Weight: 135.1 g/mol
Purity: >=98%
Type of Compound: Miscellaneous
Physical Desc.: Powder
Source: The leaves of cabbage
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $30/20mg
S-methyl-L-cysteine is a substrate in the catalytic antioxidant system mediated by methionine sulfoxide reductases (MSRs), prevents the alpha-synuclein-induced abnormalities.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Pharmaceuticals (Basel).2021, 14(7):633.
  • J.of Traditional&Complementary Med.2022, 10.1016:j.jtcme.
  • Korean J. Medicinal Crop Sci.2018, 26(2):148-156
  • Biochem Biophys Res Commun.2018, 505(1):261-266
  • ACS Pharmacol.Transl.Sci.2024, 4c00003.
  • Antioxidants (Basel).2021, 10(1):112.
  • J Chromatogr B Analyt Technol Biomed Life Sci.2019, 1113:1-13
  • Postharvest Biol Tec2019, 149:18-26
  • Molecules.2020, 25(23):5556.
  • Proc Biol Sci.2024, 291:20232298.
  • Gentiopicroside

    Catalog No: CFN98047
    CAS No: 20831-76-9
    Price: $40/20mg
    Punicalagin

    Catalog No: CFN99938
    CAS No: 65995-63-3
    Price: $108/20mg
    Isopsoralenoside

    Catalog No: CFN92225
    CAS No: 905954-18-9
    Price: $338/10mg
    Praeruptorin A

    Catalog No: CFN98139
    CAS No: 73069-25-7
    Price: $60/20mg
    Demethylsuberosin

    Catalog No: CFN96241
    CAS No: 21422-04-8
    Price: $188/20mg
    Journal of Neuroence the Official Journal of the Society for Neuroence, 2007, 27(47):12808-16.
    Methionine sulfoxide reductase A and a dietary supplement S-methyl-L-cysteine prevent Parkinson's-like symptoms.[Pubmed: 18032652]
    Parkinson's disease (PD), a common neurodegenerative disease, is caused by loss of dopaminergic neurons in the substantia nigra. Although the underlying cause of the neuronal loss is unknown, oxidative stress is thought to play a major role in the pathogenesis of PD. The amino acid methionine is readily oxidized to methionine sulfoxide, and its reduction is catalyzed by a family of enzymes called methionine sulfoxide reductases (MSRs). The reversible oxidation-reduction cycle of methionine involving MSRs has been postulated to act as a catalytic antioxidant system protecting cells from oxidative damage.
    METHODS AND RESULTS:
    Here, we show that one member of the MSR family, MSRA, inhibits development of the locomotor and circadian rhythm defects caused by ectopic expression of human alpha-synuclein in the Drosophila nervous system. Furthermore, we demonstrate that one way to enhance the MSRA antioxidant system is dietary supplementation with S-Methyl-L-cysteine (SMLC), found abundantly in garlic, cabbage, and turnips. SMLC, a substrate in the catalytic antioxidant system mediated by MSRA, prevents the alpha-synuclein-induced abnormalities.
    CONCLUSIONS:
    Therefore, interventions focusing on the enzymatic reduction of oxidized methionine catalyzed by MSRA represent a new prevention and therapeutic approach for PD and potentially for other neurodegenerative diseases involving oxidative stress.
    9-O-Acetyl-fargesol

    Catalog No: CFN95031
    CAS No: 449172-61-6
    Price: $413/5mg
    Lappaol A

    Catalog No: CFN95067
    CAS No: 62333-08-8
    Price: $333/10mg
    Notoptol

    Catalog No: CFN95218
    CAS No: 88206-49-9
    Price: $318/5mg
    Nortrachelogenin-5'-C-beta-glucoside

    Catalog No: CFN95251
    CAS No: 858127-39-6
    Price: $318/10mg
    N1,N5,N10-(Z)-tri-p-coumaroylspermidine

    Catalog No: CFN95253
    CAS No: 131086-78-7
    Price: $238/5mg
    Lariciresinol 4'-O-glucoside

    Catalog No: CFN95400
    CAS No: 107110-16-7
    Price: $318/5mg
    5-Demethylsinensetin

    Catalog No: CFN95415
    CAS No: 21763-80-4
    Price: $318/10mg
    Melitidin

    Catalog No: CFN95419
    CAS No: 1162664-58-5
    Price: $318/10mg
    erythro-Austrobailignan-6

    Catalog No: CFN95501
    CAS No: 114127-24-1
    Price: $318/10mg
    Nomilinic acid

    Catalog No: CFN95559
    CAS No: 35930-20-2
    Price: $318/5mg